SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-045421
Filing Date
2011-02-24
Accepted
2011-02-24 16:38:22
Documents
11
Period of Report
2011-02-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 41522
2 FORM OF ARTICLES OF AMENDMENT dex31.htm EX-3.1 35698
3 ARTICLES OF AMENDMENT dex32.htm EX-3.2 88926
4 FORM OF SERIES 10 PREFERRED STOCK CERTIFICATE dex41.htm EX-4.1 9259
5 FORM OF COMMON STOCK PURCHASE WARRANT dex42.htm EX-4.2 75808
6 FORM OF SERIES 11 PREFERRED STOCK CERTIFICATE dex43.htm EX-4.3 10081
7 OPINION OF KARR TUTTLE CAMPBELL dex51.htm EX-5.1 16481
8 FORM OF SECURITIES PURCHASE AGREEMENT dex101.htm EX-10.1 187606
9 PRESS RELEASE dex991.htm EX-99.1 11981
10 GRAPHIC g154343g36m15.jpg GRAPHIC 4887
11 GRAPHIC g154343g82j55.jpg GRAPHIC 3306
  Complete submission text file 0001193125-11-045421.txt   490718
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 11636882
SIC: 2834 Pharmaceutical Preparations